254 related articles for article (PubMed ID: 31280015)
1. Ultrasound-assisted synthesis of novel chalcone, heterochalcone and bis-chalcone derivatives and the evaluation of their antioxidant properties and as acetylcholinesterase inhibitors.
Polo E; Ibarra-Arellano N; Prent-Peñaloza L; Morales-Bayuelo A; Henao J; Galdámez A; Gutiérrez M
Bioorg Chem; 2019 Sep; 90():103034. PubMed ID: 31280015
[TBL] [Abstract][Full Text] [Related]
2. Effect on Acetylcholinesterase and Anti-oxidant Activity of Synthetic Chalcones having a Good Predicted Pharmacokinetic Profile.
Sakata RP; Figueiro M; Kawano DF; Almeida WP
Med Chem; 2017; 13(7):654-663. PubMed ID: 28545385
[TBL] [Abstract][Full Text] [Related]
3. Quinoline containing chalcone derivatives as cholinesterase inhibitors and their in silico modeling studies.
Shah MS; Najam-Ul-Haq M; Shah HS; Farooq Rizvi SU; Iqbal J
Comput Biol Chem; 2018 Oct; 76():310-317. PubMed ID: 30142564
[TBL] [Abstract][Full Text] [Related]
4. Anti-Cholinesterase Activity of Chalcone Derivatives: Synthesis, In Vitro Assay and Molecular Docking Study.
Riswanto FDO; Rawa MSA; Murugaiyah V; Salin NH; Istyastono EP; Hariono M; Wahab HA
Med Chem; 2021; 17(5):442-452. PubMed ID: 31808389
[TBL] [Abstract][Full Text] [Related]
5. Novel Potent and Selective Acetylcholinesterase Inhibitors as Potential Drugs for the Treatment of Alzheimer's Disease: Synthesis, Pharmacological Evaluation, and Molecular Modeling of Amino-Alkyl-Substituted Fluoro-Chalcones Derivatives.
Liu HR; Zhou C; Fan HQ; Tang JJ; Liu LB; Gao XH; Wang QA; Liu WK
Chem Biol Drug Des; 2015 Oct; 86(4):517-22. PubMed ID: 25588967
[TBL] [Abstract][Full Text] [Related]
6. Small Multitarget Molecules Incorporating the Enone Moiety.
Liargkova T; Eleftheriadis N; Dekker F; Voulgari E; Avgoustakis C; Sagnou M; Mavroidi B; Pelecanou M; Hadjipavlou-Litina D
Molecules; 2019 Jan; 24(1):. PubMed ID: 30621100
[TBL] [Abstract][Full Text] [Related]
7. Simple chalcones and bis-chalcones ethers as possible pleiotropic agents.
Liargkova T; Hadjipavlou-Litina DJ; Koukoulitsa C; Voulgari E; Avgoustakis C
J Enzyme Inhib Med Chem; 2016; 31(2):302-13. PubMed ID: 25798685
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, anti-acetylcholinesterase evaluation and molecular modelling studies of novel coumarin-chalcone hybrids.
Hasan AH; Shakya S; Hussain FHS; Murugesan S; Chander S; Pratama MRF; Jamil S; Das B; Biswas S; Jamalis J
J Biomol Struct Dyn; 2023; 41(21):11450-11462. PubMed ID: 36591704
[TBL] [Abstract][Full Text] [Related]
9. Exploiting the Chalcone Scaffold to Develop Multifunctional Agents for Alzheimer's Disease.
Rampa A; Bartolini M; Pruccoli L; Naldi M; Iriepa I; Moraleda I; Belluti F; Gobbi S; Tarozzi A; Bisi A
Molecules; 2018 Jul; 23(8):. PubMed ID: 30061534
[TBL] [Abstract][Full Text] [Related]
10. Novel thiophene Chalcones-Coumarin as acetylcholinesterase inhibitors: Design, synthesis, biological evaluation, molecular docking, ADMET prediction and molecular dynamics simulation.
Hasan AH; Murugesan S; Amran SI; Chander S; Alanazi MM; Hadda TB; Shakya S; Pratama MRF; Das B; Biswas S; Jamalis J
Bioorg Chem; 2022 Feb; 119():105572. PubMed ID: 34971946
[TBL] [Abstract][Full Text] [Related]
11. Cholinesterases inhibition and molecular modeling studies of piperidyl-thienyl and 2-pyrazoline derivatives of chalcones.
Shah MS; Khan SU; Ejaz SA; Afridi S; Rizvi SUF; Najam-Ul-Haq M; Iqbal J
Biochem Biophys Res Commun; 2017 Jan; 482(4):615-624. PubMed ID: 27865835
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and evaluation of chalcone Mannich base derivatives as multifunctional agents for the potential treatment of Alzheimer's disease.
Zhang X; Song Q; Cao Z; Li Y; Tian C; Yang Z; Zhang H; Deng Y
Bioorg Chem; 2019 Jun; 87():395-408. PubMed ID: 30921741
[TBL] [Abstract][Full Text] [Related]
13. DFT Study of Regio- and Stereoselective 13DC Reaction between Diazopropane and Substituted Chalcone Derivatives: Molecular Docking of Novel Pyrazole Derivatives as Anti-Alzheimer's Agents.
Al-Hazmy SM; Zouaghi MO; Amri N; Arfaoui Y; Alhagri IA; Hamdi N
Molecules; 2023 Feb; 28(4):. PubMed ID: 36838888
[TBL] [Abstract][Full Text] [Related]
14. Development of chalcone-O-alkylamine derivatives as multifunctional agents against Alzheimer's disease.
Bai P; Wang K; Zhang P; Shi J; Cheng X; Zhang Q; Zheng C; Cheng Y; Yang J; Lu X; Sang Z
Eur J Med Chem; 2019 Dec; 183():111737. PubMed ID: 31581002
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, biological evaluation and molecular modeling studies of modulated benzyloxychalcones as potential acetylcholinesterase inhibitors.
Abdalla Ali A; Mhamad SA; Hasan AH; Ahmad I; Abdullah SA; Jamil S; Patel H; Murugesan S; Jamalis J
J Biomol Struct Dyn; 2024 Apr; 42(7):3604-3615. PubMed ID: 37293930
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, Biological Evaluation and Molecular Modelling of 2'-Hydroxychalcones as Acetylcholinesterase Inhibitors.
Sukumaran SD; Chee CF; Viswanathan G; Buckle MJ; Othman R; Abd Rahman N; Chung LY
Molecules; 2016 Jul; 21(7):. PubMed ID: 27455222
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and Molecular Docking of New Bis-Thiazolidinone-Based Chalcone Analogs as Effective Inhibitors of Acetylcholinesterase and Butyrylcholinesterase.
Hussain R; Rahim F; Rehman W; Taha M; Khan S; Zaman K; Adnan Ali Shah S; Wadood A; Imran S; Abdellatif MH
Chem Biodivers; 2022 Oct; 19(10):e202200323. PubMed ID: 35997224
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, biological evaluation and molecular modeling of aloe-emodin derivatives as new acetylcholinesterase inhibitors.
Shi DH; Huang W; Li C; Wang LT; Wang SF
Bioorg Med Chem; 2013 Mar; 21(5):1064-73. PubMed ID: 23380475
[TBL] [Abstract][Full Text] [Related]
19. Analogues of 2'-hydroxychalcone with modified C4-substituents as the inhibitors against human acetylcholinesterase.
Sukumaran SD; Nasir SB; Tee JT; Buckle MJC; Othman R; Rahman NA; Lee VS; Bukhari SNA; Chee CF
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):130-137. PubMed ID: 33243025
[TBL] [Abstract][Full Text] [Related]
20. Multifunctional novel Diallyl disulfide (DADS) derivatives with β-amyloid-reducing, cholinergic, antioxidant and metal chelating properties for the treatment of Alzheimer's disease.
Manral A; Saini V; Meena P; Tiwari M
Bioorg Med Chem; 2015 Oct; 23(19):6389-403. PubMed ID: 26337018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
